Evidence map›Paper›PMID 33249605›Full record

ArticleNeuropathology and applied neurobiology2021

Intracerebral endotheliitis and microbleeds are neuropathological features of COVID-19.

Daniel Kirschenbaum, Lukas L Imbach, Elisabeth J Rushing, Katrin B M Frauenknecht, Dominic Gascho, Benjamin V Ineichen, Emanuela Keller, Sibylle Kohler, Mona Lichtblau, Regina R Reimann and 5 more

Abstract read
In one paragraph

Article in Neuropathology and applied neurobiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Neuroimmune pathophysiology of long COVID.Psychiatry and clinical neurosciences · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Postmortem neuropathology in COVID-19: An update.Brain pathology (Zurich, Switzerland) · 2023
    Article
  17. Article
  18. Review
  19. Review
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Daniel KirschenbaumInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.
Lukas L ImbachDepartment of Neurology, University of Zurich, Zurich, Switzerland.
Elisabeth J RushingInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.
Katrin B M FrauenknechtInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.
Dominic GaschoInstitute of Forensic Medicine, University of Zurich, Zurich, Switzerland.ORCID 0000-0001-9004-4362
Benjamin V IneichenCenter for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Emanuela KellerDepartment of Neurosurgery and Institute of Intensive Care Medicine, University of Zurich, Zurich, Switzerland.
Sibylle KohlerDepartment of Internal Medicine, Spital Zollikerberg, Zollikerberg, Switzerland.
Mona LichtblauDepartment of Pulmonology, University of Zurich, Zurich, Switzerland.
Regina R ReimannInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.
Katharina SchreibDepartment of Internal Medicine, Spital Zollikerberg, Zollikerberg, Switzerland.
Silvia UlrichDepartment of Pulmonology, University of Zurich, Zurich, Switzerland.
Peter SteigerInstitute of Intensive Care Medicine, University of Zurich, Zurich, Switzerland.
Adriano AguzziInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.
Karl FrontzekInstitute of Neuropathology, University of Zurich, Zurich, Switzerland.ORCID 0000-0002-0945-8857

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 19 (COVID-19) is a rapidly evolving pandemic caused by the coronavirus Sars-CoV-2. Clinically manifest central nervous system symptoms have been described in COVID-19 patients and could be the consequence of commonly associated vascular pathology, but the detailed neuropathological sequelae remain largely unknown. A total of six cases, all positive for Sars-CoV-2, showed evidence of cerebral petechial hemorrhages and microthrombi at autopsy. Two out of six patients showed an elevated risk for disseminated intravascular coagulopathy according to current criteria and were excluded from further analysis. In the remaining four patients, the hemorrhages were most prominent at the grey and white matter junction of the neocortex, but were also found in the brainstem, deep grey matter structures and cerebellum. Two patients showed vascular intramural inflammatory infiltrates, consistent with Sars-CoV-2-associated endotheliitis, which was associated by elevated levels of the Sars-CoV-2 receptor ACE2 in the brain vasculature. Distribution and morphology of patchy brain microbleeds was clearly distinct from hypertension-related hemorrhage, critical illness-associated microbleeds and cerebral amyloid angiopathy, which was ruled out by immunohistochemistry. Cerebral microhemorrhages in COVID-19 patients could be a consequence of Sars- CoV-2-induced endotheliitis and more general vasculopathic changes and may correlate with an increased risk of vascular encephalopathy.

Indexed as

AgedAged, 80 and overCerebral HemorrhageCOVID-19Endothelial CellsFemaleHumansMaleRetrospective StudiesSARS-CoV-2Vasculitis, Central Nervous SystemACE2COVID19endotheliitisSars-CoV-2

Identifiers

PMID33249605
PMCPMC7753688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.